dual antiplatelet therapy的意思|示意
双重抗血小板治疗
dual antiplatelet therapy的网络常见释义
抗血小板疗法 接受侵入式程序治疗的和处于中危或高危的病人应当接受双联抗血小板疗法(dual antiplatelet therapy)---包括阿司匹林和另一种抗血小板药物---来进行治疗。
双联抗血小板治疗 随着极晚期血栓越来越为 人们所关注，临床上使用双联抗血小板治疗（dual antiplatelet therapy，DAPT）的时间早已超过了指 南超过的时间。
双联抗血小板疗法 ...ronary intervention ，PCI）后使用三联疗法（ triple therapy ，TT）即华法林+双联抗血小板疗法（ dual antiplatelet therapy ，DAPT）的安全性及有效性。方法：这是一项单中心、回顾性研究。
联合双联抗血小板疗法 ...联合双联抗血小板疗法防治大鼠自体微血栓所致冠状动脉微栓塞 -论文 所属专业: 论文摘要: 目的: 探讨脑心通胶囊(Naoxintong capsule, （略）双联抗血小板疗法(dual antiplatelet therapy, DA )对大鼠自体冠状动脉微栓塞( coronary microembo（略）on, CME)的治疗效果.
dual antiplatelet therapy相关例句
The FDA also recommends prolonged dual antiplatelet therapy for at least a year following the intervention.
FDA也推荐介入治疗后至少延长一年对病人进行双重抗血小板治疗。
Extended medication with dual antiplatelet therapy was required because dose reduction to aspirin monotherapy worsened symptoms.
由于阿司匹林单一疗法可导致症状加重，需要使用双重抗血小板疗法。
DES recipients had longer and more complex lesions than BMS recipients and also were more likely to be receiving dual antiplatelet therapy at 1 year.
接受药物洗脱支架的患者长病变和复杂病变比接受裸金属支架的患者多，而且接受双重抗血小板治疗1年的可能性较大。
The optimal duration of dual antiplatelet therapy depends on the specific cardiac indication (see other articles in this supplement) for recommended for specific indications.
双重抗血小板治疗的最佳持续时间取决于特定心脏指征(见本增刊中其他篇目)。
Although it is presumed that prevention of venous thrombosis is best achieved with anticoagulation, dual antiplatelet therapy can be a substitute for patients with poor compliance.
尽管普遍认为抗凝疗法可预防静脉血栓形成，双重抗血小板疗法仍可用来治疗适应性较差的患者。
Among those with late and very late ST, the prevalence of dual-antiplatelet therapy was 57% and 36%, respectively.
在发生晚期和极晚期ST的患者中，双重抗血小板的应用比例分别占57%和36%。